Trial Profile
Ictal and Interictal Inflammatory Markers in Migraine.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Oct 2023
Price :
$35
*
At a glance
- Drugs Naproxen sodium/sumatriptan (Primary)
- Indications Migraine
- Focus Biomarker; Therapeutic Use
- 22 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Apr 2013 Lead trial centres amended as reported by ClinicalTrials.gov.
- 03 Apr 2013 Planned End Date changed from 1 Jan 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.